Pharmacological treatment of psychiatric comorbidity in patients with refractory epilepsy

Epilepsy and Behavior

Volumn 29, Issue 1, 2013, Pages 77-81

  Karouni, Mohamad ^a   Henning, Oliver ^b   Larsson, Pål G ^b   Johannessen, Svein I ^b   Johannessen Landmark, Cecilie ^c  

^a Jæren Apotek Varhaug ^*  (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c OSLO METROPOLITAN UNIVERSITY   (Norway)

Author keywords

Antiepileptic drugs; Epilepsy; Psychiatric comorbidity; Psychotropic drugs

Indexed keywords

ACETAZOLAMIDE; CARBAMAZEPINE; DIAZEPAM; ESCITALOPRAM; ESLICARBAZEPINE ACETATE; ETHOSUXIMIDE; ETIRACETAM; FELBAMATE; HARKOSERIDE; LAMOTRIGINE; NITRAZEPAM; OLANZAPINE; OXAZEPAM; PREGABALIN; QUETIAPINE; RISPERIDONE; STIRIPENTOL; SULTIAME; TIAGABINE; VALPROIC ACID; VIGABATRIN;

AGED; ARTICLE; CHILD; COGNITION; COMORBIDITY; DEPRESSION; DRUG UTILIZATION; EPILEPSY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; POLYPHARMACY; PREVALENCE; RETROSPECTIVE STUDY; SCHOOL CHILD; SEX DIFFERENCE;

ANTIEPILEPTIC DRUGS; EPILEPSY; PSYCHIATRIC COMORBIDITY; PSYCHOTROPIC DRUGS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; DRUG THERAPY, COMBINATION; EPILEPSY; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; NORWAY; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTROPIC DRUGS; YOUNG ADULT;

EID: 84882249933     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2013.06.031     Document Type: Article

References (31)

1. Kanner A.M., Schachter S.C., Barry J.J., Hersdorffer D.C., Mula M., Trimble M., et al. Depression and epilepsy, pain and psychogenic non-epileptic seizures: clinical and therapeutic perspectives. Epilepsy Behav 2012, 24(2):169-181.
2. Tellez-Zenteno J.F., Patten S.B., Jetté N., Williams J., Wiebe S. Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia 2007, 48(12):2236-2244.
3. Fuller-Thomson E., Brennenstuhl S. The association between depression and epilepsy in a nationally representative sample. Epilepsia 2009, 50(5):1051-1058.
4. Stefanello S., Marín-Léon L., Fernandes P.T., Li L.M., Botega N.J. Psychiatric comorbidity and suicidal behavior in epilepsy: a community-based case-control study. Epilepsia 2010, 51(7):1120-1125.
5. Karouni M., Arulthas S., Larsson P.G., Rytter E., Johannessen S.I., Johannessen Landmark C. Psychiatric comorbidity in patients with epilepsy: a population-based study. Eur J Clin Pharmacol 2010, 66(11):1151-1160.
6. Gilliam F. Optimizing health outcomes in active epilepsy. Neurology 2002, 58(8 Suppl. 5):S9-S20.
7. Hitris N., Mohanraj R., Norrie J., Sills G.J., Brodie M.J. Predictors of pharmacoresistant epilepsy. Epilepsy Res 2007, 75(2-3):192-196.
8. Desai S.D., Shukla G., Goyal V., Singh S., Padma M.V., Tripathi M., et al. Study of DSM-IV Axis I psychiatric disorders in patients with refractory complex partial seizures using a short structured clinical interview. Epilepsy Behav 2010, 19(3):301-305.
9. Dalmagro C.L., Velasco T.R., Biachin M.M., Martins A.P., Guarnieri R., Cescato M.P., et al. Psychiatric comorbidity in refractory focal epilepsy: a study of 490 patients. Epilepsy Behav 2012, 25(4):593-597.
10. WHO collaborating center Available at:. http://www.whocc.no.
11. ICD-10 classification system Available at:. http://www.who.int/classifications/icd/en/.
12. The Norwegian Prescription Registry Available at:. http://www.reseptregisteret.no.
13. Statistics Norway Available at:. http://www.ssb.no.
14. Fakhoury T.A., Barry J.J., Mitchell Miller J., Hammer A.E., Vuong A. Lamotrigine in patients with epilepsy and comorbid depressive symptoms. Epilepsy Behav 2006, 10:155-162.
15. Thompson A.W., Miller J.W., Katon W., Chaytor N., Ciechanowski P. Sociodemographic and clinical factors associated with depression in epilepsy. Epilepsy Behav 2009, 14(4):655-660.
16. Johannessen Landmark C., Larsson P.G., Rytter E., Johannessen S.I. Antiepileptic drugs in epilepsy and other disorders: a population-based study of prescriptions. Epilepsy Res 2009, 87:31-39.
17. Johannessen Landmark C., Rytter E., Johannessen S.I. Clinical use of antiepileptic drugs at a referral center for epilepsy. Seizure 2007, 16:356-364.
18. Perucca P., Mula M. Antiepileptic drug effects on mood and behaviour: molecular targets. Epilepsy Behav 2013, 26(3):440-449.
19. Rytter E., Johannessen Landmark C., Johannessen S.I. Admission of children to a referral center for epilepsy - does it make a difference?. Seizure 2009, 18(8):573-579.
20. Johannessen Landmark C., Fossmark H., Larsson P.G., Rytter E., Johannessen S.I. Antiepileptic drug use in epilepsy-a population-based study. Epilepsy Res 2011, 95:51-59.
21. Henning O., Nakken K.O. Psychiatric comorbidity and use of psychotropic drugs in epilepsy patients. Acta Neurol Scand Suppl 2010, 190:18-22.
22. Kühn K.U., Quednow B.B., Thiel M., Falkai P., Maier W., Elger C.E. Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants. Epilepsy Behav 2003, 4(6):674-679.
23. Barry J.J., Ettinger A.B., Friel P., Gilliam F.G., Harden C.L., Hermann B., et al. Consensus statement: the evaluation and treatment of people with epilepsy and affective disorders. Epilepsy Behav 2008, 13(Suppl. 1):S1-S29.
24. Parisi P., Moavero R., Verrotti A., et al. Attention deficit hyperactivity disorder in children with epilepsy. Brain Dev 2010, 32:10-16.
25. Johannessen Landmark C., Patsalos P.N. Drug interactions involving the newer second- and third-generation antiepileptic drugs. Expert Rev Neurother 2010, 10(1):19-40.
26. Mula M. Anticonvulsants-antidepressants pharmacokinetic interactions: the role of the CYP P450 system in psychopharmacology. Curr Drug Metab 2008, 9(8):730-737.
27. Besag F.M., Berry D. Interactions between antiepileptic and antipsychotic drugs. Drug Saf 2006, 29(2):95-118.
28. Patsalos P.N., Berry D.J., Bourgeois B.F., Cloyd J.C., Glauser T.A., Johannessen S.I., et al. Antiepileptic drugs-best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring. ILAE Commission on Therapeutic Strategies. Epilepsia 2008, 49(7):1239-1276.
29. Waade R.B., Molden E., Refsum H., Hermann M. Serum concentrations of antidepressants in the elderly. Ther Drug Monit 2012, 34(1):25-30.
30. Cleary R.A., Thompson P.J., Fox Z., Foong J. Predictors of psychiatric and seizure outcome following temporal lobe epilepsy surgery. Epilepsia 2012, 53(10):1705-1712.
31. Filho G.M., Mazetto L., Gomes F.L., Marinho M.M., Tavares I.M., Caboclo L.O., et al. Pre-surgical predictors for psychiatric disorders following epilepsy surgery in patients with refractory temporal lobe epilepsy and mesial temporal sclerosis. Epilepsy Res 2012, 102(1-2):86-93.